347850 — DND Pharmatech Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩638bn
- KR₩617bn
- KR₩11bn
Annual cashflow statement for DND Pharmatech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | — | -72,047 | -163,513 | 4,494 | -30,357 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | — | 2,416 | 99,231 | -13,690 | 7,968 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -48,580 | 5,785 | -2,541 | -4,350 | -4,943 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -48,580 | -51,945 | -53,083 | -9,117 | -21,805 |
| Capital Expenditures | -3,108 | -2,218 | -719 | -45.2 | -416 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -225 | 263 | 240 | 313 | -124 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3,333 | -1,955 | -479 | 268 | -540 |
| Financing Cash Flow Items | — | 9,077 | 3,217 | -4.67 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 106 | 67,692 | 1,986 | -630 | 36,251 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -52,446 | 15,346 | -50,454 | -9,862 | 14,372 |